Moderna, the pharmaceutical company, which developed the well-known coronavirus vaccine, is working on a new life-saving vaccine for cancer, heart disease, and other autoimmune diseases. Successful vaccination trials suggest a global commercial distribution of the vaccine by the end of 2030.
Moderna says it hopes to offer new vaccines for cancer, heart disease, and other conditions by 2030https://t.co/WA04y3KFuA— CNBC (@CNBC) April 10, 2023
The mRNA technology used in the production of this new vaccine is now speeding up a revolution in the medical world. Scientists say that we have made almost 15 years' worth of progress in the last 12-18 months due to this technology, and it's all because of the COVID-19 vaccine's success.
In an interview with The Guardian, Dr. Paul Burton, the chief medical officer of Moderna, said:
“This vaccine is going to be here, will be extremely effective, and potentially save millions of lives. I believe we will be able to provide individuals all around the world with tailored cancer vaccines against a variety of different tumor forms."
He further added: “The company will be able to provide these medicines for all types of infectious diseases in as little as five years”.
Moreover, this vaccine will help deal with multiple respiratory infections with a single injection, protecting the vulnerable population from flu, covid, and respiratory viruses.
Researchers have studied all the areas of infectious disease types and are confident that the groundbreaking vaccine will be applied to cancer, infectious diseases, cardiovascular and autoimmune diseases, and other rare infections as well.
Doctors from Hameed Latif Hospital say that the addition of this vaccine to the medical world will truly be a revolution, as it will help save millions of lives around the world.